MedTrace Logo

Epidural Study of Patients With Chronic Lower Back Pain

NCT00887003 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 252

Last updated 2012-02-08

No results posted yet for this study

Summary

The purpose of this study is to examine 4 different epidural dosing regimes of local anaesthetic solution in a series of 3 epidural injections over a period of 12 months to determine the optimum dose of anaesthetic solution for pain relief and to determine the nature of any adverse events by measuring anxiety and depression, functionality and any side effects of the medication.

Conditions

  • Chronic Low Back Pain

Interventions

DRUG

Bupivacaine

Low Volume, Low Dose (5cc, 5mg plain Bupivacaine)

DRUG

Bupivacaine

Low Volume, High Dose (5cc, 10mg plain Bupivacaine)

DRUG

Bupivacaine

High Volume, Low Dose (10cc, 5mg plain Bupivacaine)

DRUG

Bupivacaine

High Volume, High Dose (10cc, 10mg plain Bupivacaine)

DRUG

Depo-Medrol

80mg Depo-Medrol

Sponsors & Collaborators

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Julian Mulcaster, MD · Hamilton Health Sciences Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2011-08-31
Completion
2011-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00887003 on ClinicalTrials.gov